Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

FDA approves sibutramine for the treatment of obesity

Nov. 25, 1997

Bayer introduces statin in Germany

Nov. 25, 1997

Novel beta-agonists for obesity and diabetes described by SmithKline Beecham

Nov. 25, 1997

Dainippon's aldose reductase inhibitor in preclinical testing

Nov. 25, 1997

Novartis launches once-monthly formulation of Sandostatin

Nov. 24, 1997

Role of substance P in PTH secretion described

Nov. 24, 1997

GH secretagogues under development at Merck & Co.

Nov. 24, 1997

Clinical trial demonstrates efficacy of NPS-R-568 in hyperparathyroidism

Nov. 24, 1997

Olpadronate associated with improvement in osteogenesis imperfecta

Nov. 24, 1997

Amylin, SIDDCO join forces for metabolic drug discovery

Nov. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...